CD96 and breast cancer: Previous studies of CD96 expression focused on its roles in NK cells, T cells, and human acute myeloid leukemia.[5, 7, 11, 12, 14, 15, 16] We discovered that there is a subpopulation of CD96+ cells in BC and found that their proportion is directly connected to disease progression.